Bone Biologics Corp Analysis
| Analyst Ratings |
|
Average Target Price
|
4.88
|
|
Average Rating
|
5.00
|
|
# Strong Buys
|
1
|
|
# Buys
|
0
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-03-31
|
-0.16
|
0.00
|
0.16
|
100.00%
|
|
2022-12-31
|
-0.23
|
0.00
|
0.23
|
100.00%
|
|
2022-09-30
|
-0.15
|
-0.12
|
0.03
|
20.00%
|
|
2022-06-30
|
-0.12
|
-0.05
|
0.07
|
58.33%
|
|
2022-03-31
|
-0.20
|
-0.07
|
0.13
|
65.00%
|
|
2021-12-31
|
-0.17
|
-0.05
|
0.12
|
70.59%
|
|
2021-09-30
|
-0.17
|
-0.17
|
0.00
|
0.00%
|
|
2021-06-30
|
0.00
|
-0.07
|
0.00
|
0.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.24
|
|
2021-12-31
|
-0.37
|
|
2020-12-31
|
-0.51
|
|
2019-12-31
|
-0.47
|
|
2018-12-31
|
-0.76
|
|
2017-12-31
|
-1.62
|
|
2016-12-31
|
-14.13
|